Patents by Inventor Mijung Kwon

Mijung Kwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FILIP1L compositions and methods for treating cancer
    Publication number: 20160176935
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO: 1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Application
    Filed: March 1, 2016
    Publication date: June 23, 2016
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle
  • FILIP1L nucleic acid fragments
    Patent number: 9279009
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO:1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: March 8, 2016
    Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle
  • FILIP1L COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20140039041
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO: 1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Application
    Filed: July 26, 2013
    Publication date: February 6, 2014
    Applicant: The United States of America, as Represented by the Secretary, Department of Health & Human Servic
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle
  • DOC1 COMPOSITIONS AND METHODS FOR TREATING CANCER
    Publication number: 20110053850
    Abstract: A purified DOC1 polypeptide comprising a fragment of SEQ ID NO: 1 is provided, wherein the DOC1 polypeptide is not the full-length DOC1 polypeptide sequence. A method of inhibiting angiogenesis in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting angiogenesis. A method of inhibiting tumor growth in a subject is provided comprising administering to a subject a nucleic acid encoding a DOC1 polypeptide, whereby a cell in the subject produces the DOC1 polypeptide, thus inhibiting tumor growth.
    Type: Application
    Filed: December 8, 2008
    Publication date: March 3, 2011
    Applicant: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HS
    Inventors: Steven K. Libutti, Mijung Kwon, Anita Tandle
  • Anti-angiogenic polypeptides
    Patent number: 7626008
    Abstract: Anti-angiogenic polypeptides A61 or p22 are disclosed. Also disclosed are methods of making the polypeptides and methods of treating subjects having angiogenic diseases or conditions.
    Type: Grant
    Filed: July 31, 2008
    Date of Patent: December 1, 2009
    Inventors: David M. Waisman, Geeth Kassam, Mijung Kwon
  • ANTI-ANGIOGENIC POLYPEPTIDES
    Publication number: 20090061510
    Abstract: Anti-angiogenic polypeptides A61 or p22 are disclosed. Also disclosed are methods of making the polypeptides and methods of treating subjects having angiogenic diseases or conditions.
    Type: Application
    Filed: July 31, 2008
    Publication date: March 5, 2009
    Inventors: David M. Waisman, Geeth Kassam, Mijung Kwon
  • Anti-angiogenic polypeptides
    Patent number: 7420036
    Abstract: Anti-angiogenic polypeptides A61 or p22 are disclosed. Also disclosed are methods of making the polypeptides and methods of treating subjects having angiogenic diseases or conditions.
    Type: Grant
    Filed: November 28, 2001
    Date of Patent: September 2, 2008
    Inventors: David M. Waisman, Geetha Kassam, Mijung Kwon
  • Anti-angiogenesis methods, compositions and uses therefor
    Patent number: 7250271
    Abstract: This invention relates generally to methods of producing peptide-based anti-angiogenesis compounds using plasmin reductases, and specifically to methods of producing an A61 anti-angiogenic plasmin fragment using an annexin II heterotetramer or subunit thereof. This invention also relates to anti-angiogenesis methods and compositions comprising a plasmin reductase or polynucleotides encoding subunits thereof. Compositions useful for the inhibition or promotion of angiogenesis are also disclosed.
    Type: Grant
    Filed: November 26, 2002
    Date of Patent: July 31, 2007
    Inventors: David Waisman, Mijung Kwon
  • Anti-angiogenic polypeptides
    Publication number: 20040082030
    Abstract: Anti-angiogenic polypeptides A61 or p22 are disclosed. Also disclosed are methods of making the polypeptides and methods of treating subjects having angiogenic diseases or conditions.
    Type: Application
    Filed: April 22, 2003
    Publication date: April 29, 2004
    Inventors: David M. Waisman, Geetha Kassam, Mijung Kwon
  • Anti-angiogenesis methods, compositions and uses therefor
    Publication number: 20030083234
    Abstract: This invention relates generally to methods of producing peptide-based anti-angiogenesis compounds using plasmin reductases, and specifically to methods of producing an A61 anti-angiogenic plasmin fragment using an annexin II heterotetramer or subunit thereof. This invention also relates to anti-angiogenesis methods and compositions comprising a plasmin reductase or polynucleotides encoding subunits thereof. Compositions useful for the inhibition or promotion of angiogenesis are also disclosed.
    Type: Application
    Filed: November 26, 2002
    Publication date: May 1, 2003
    Inventors: David Waisman, Mijung Kwon